Mustang Bio Statistics
Total Valuation
Mustang Bio has a market cap or net worth of $3.53 million. The enterprise value is -$953,355.
| Market Cap | 3.53M |
| Enterprise Value | -953,355 |
Important Dates
The next estimated earnings date is Friday, May 10, 2024, after market close.
| Earnings Date | May 10, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Mustang Bio has 10.39 million shares outstanding. The number of shares has increased by 11.97% in one year.
| Shares Outstanding | 10.39M |
| Shares Change (YoY) | +11.97% |
| Shares Change (QoQ) | +22.65% |
| Owned by Insiders (%) | 22.77% |
| Owned by Institutions (%) | 10.10% |
| Float | 6.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 28.72 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.74, with a Debt / Equity ratio of 20.31.
| Current Ratio | 0.74 |
| Quick Ratio | 0.71 |
| Debt / Equity | 20.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.56 |
Financial Efficiency
Return on equity (ROE) is -433.10% and return on invested capital (ROIC) is -1,879.44%.
| Return on Equity (ROE) | -433.10% |
| Return on Assets (ROA) | -146.40% |
| Return on Capital (ROIC) | -1,879.44% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$645,025 |
| Employee Count | 80 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.68% in the last 52 weeks. The beta is 1.54, so Mustang Bio's price volatility has been higher than the market average.
| Beta (1Y) | 1.54 |
| 52-Week Price Change | -91.68% |
| 50-Day Moving Average | 0.98 |
| 200-Day Moving Average | 2.04 |
| Relative Strength Index (RSI) | 22.24 |
| Average Volume (30 Days) | 209,285 |
Short Selling Information
The latest short interest is 177,977, so 1.71% of the outstanding shares have been sold short.
| Short Interest | 177,977 |
| Short Previous Month | 389,026 |
| Short % of Shares Out | 1.71% |
| Short % of Float | 2.77% |
| Short Ratio (days to cover) | 0.54 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -49.26M |
| Pretax Income | -51.60M |
| Net Income | -51.60M |
| EBITDA | -45.27M |
| EBIT | -47.49M |
| Earnings Per Share (EPS) | -$6.00 |
Balance Sheet
The company has $6.98 million in cash and $2.50 million in debt, giving a net cash position of $4.49 million or $0.43 per share.
| Cash & Cash Equivalents | 6.98M |
| Total Debt | 2.50M |
| Net Cash | 4.49M |
| Net Cash Per Share | $0.43 |
| Equity / Book Value | 123,000 |
| Book Value Per Share | 0.01 |
| Working Capital | -4.03M |
Cash Flow
In the last 12 months, operating cash flow was -$49.48 million and capital expenditures $5.94 million, giving a free cash flow of -$43.54 million.
| Operating Cash Flow | -49.48M |
| Capital Expenditures | 5.94M |
| Free Cash Flow | -43.54M |
| FCF Per Share | -$5.06 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Mustang Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.97% |
| Shareholder Yield | -11.97% |
| Earnings Yield | -1,460.72% |
| FCF Yield | -1,232.53% |
Analyst Forecast
The average price target for Mustang Bio is $19.67, which is 5,685.29% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.67 |
| Price Target Difference | 5,685.29% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on April 4, 2023. It was a reverse split with a ratio of 1:15.
| Last Split Date | Apr 4, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |